Rare Disease Diversity Coalition Formed To End Racial Disparities In Rare Disease Diagnosis, Research And Treatment
NBA Champion Alonzo Mourning, White House COVID Health Equity Task Force Chair Dr. Marcella Nunez-Smith, Rep. G. K. Butterfield and Leading Rare Disease Experts to Join RDDC on February 23rd for Launch of Diversity Coalition
News provided by
Share this article
Share this article
WASHINGTON, Feb. 23, 2021 /PRNewswire/ Today, the Black Women s Health Imperative (BWHI) hosts the first public meeting of the Rare Disease Diversity Coalition (RDDC). RDDC seeks to address the pressing challenges faced by marginalized populations and identify potential solutions. Led by BWHI and comprised of a diverse group of healthcare organizations, patient advocacy groups, and industry experts, the RDDC is poised to achieve action in the years to come by:
Philadelphia
Pennsylvania
United-states
The-white-house
District-of-columbia
Washington
America
American
Deric-dube
Beverley-francis-gibson
Laura-weidner
Donna-cryer
Avidity Biosciences Announces Changes to its Board of Directors
Tamar Thompson and Jean Kim appointed to Board of Directors replacing Todd Brady and Michael Martin
News provided by
Share this article
Share this article
LA JOLLA, Calif., Jan. 11, 2021 /PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs
™), today announced the appointment of experienced health policy strategist, Tamar Thompson and recognized healthcare investment partner, Jean Kim, to its Board of Directors, who are replacing Todd Brady and Michael Martin. Avidity also announced that Troy Wilson has transitioned from Executive Chairman to Chairman.
Stanford-university
California
United-states
Juniper-point
Washington
La-jolla
Merrill-lynch
Todd-brady
Troy-wilson
Sarah-boyce
Tamar-thompson
Jean-kim